NeuroMetrix to Present at Upcoming Biotech Showcase and Digital Medicine Showcase Conferences
January 03 2018 - 11:00AM
NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai
N. Gozani M.D., Ph.D., President and Chief Executive Officer, will
be presenting at the 10th Annual Biotech Showcase 2018 Conference
at the Hilton San Francisco Union Square on Monday,
January 8 at 11:00 a.m. (Pacific). A live webcast will be
available on the investor relations page at www.NeuroMetrix.com and
will be archived after the event. Dr. Gozani will also
present at the Digital Medicine & Medtech Showcase on Tuesday,
January 9 at 1:00 p.m. (Pacific) which will not be webcast.
Both talks will highlight the Company's Quell® Wearable Pain
Relief Technology™ and provide an update on the Company’s business
activities.
About Quell
Quell is an advanced, wearable technology for treating chronic
pain. It can be worn during the day while active and at night
while sleeping. Quell is drug-free and has been cleared by
the FDA for treatment of chronic pain without a
prescription. Quell users can personalize and manage therapy
discreetly via the Quell app. Quell also offers health
tracking relevant to chronic pain sufferers including pain, sleep,
activity, and gait. Quell users can synchronize their data
with the Quell Health Cloud, which provides customized feedback and
powers one of the world’s largest chronic pain databases.
Quell is available online and through select retailers.
Visit QuellRelief.com for more information.
About NeuroMetrix
NeuroMetrix is an innovation driven healthcare company
combining neurostimulation and digital health to address chronic
health conditions including chronic pain, diabetes, and sleep
disorders. The company's lead product is Quell, an over-the-counter
wearable therapeutic device for chronic pain. The company
also markets DPNCheck®, a rapid point-of-care test for diabetic
neuropathy, which is the most common long-term complication of Type
2 diabetes. For more information, please
visit NeuroMetrix.com.
NeuroMetrix, Inc. Thomas T. Higgins, 781-314-2761 SVP and Chief
Financial Officer neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Jun 2024 to Jul 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Jul 2023 to Jul 2024